Kim YI et al. |
Effects of 15-deoxy-∆¹²,¹â´-prostaglandin Jâ‚‚ on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide. |
2011 |
Mol. Biol. Rep. |
pmid:20174873
|
Lotz C et al. |
Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. |
2011 |
Exp. Physiol. |
pmid:21123361
|
Wang P et al. |
Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. |
2011 |
PLoS ONE |
pmid:22096605
|
Murata T et al. |
Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22106279
|
Du H et al. |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. |
2011 |
Br. J. Pharmacol. |
pmid:21501147
|
Raman P et al. |
15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. |
2011 |
Mol. Pharmacol. |
pmid:21511917
|
Tanaka A et al. |
Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. |
2011 |
Am. J. Physiol., Cell Physiol. |
pmid:21865589
|
Bräutigam K et al. |
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. |
2011 |
J. Cancer Res. Clin. Oncol. |
pmid:20878528
|
Alves C et al. |
Effects of 15d-PGJâ‚‚-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. |
2011 |
Br. J. Pharmacol. |
pmid:20883476
|
Liu H et al. |
Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. |
2011 |
Neurobiol. Dis. |
pmid:20933087
|
Tao H and Hajri T |
Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists. |
2011 |
Biochem. Pharmacol. |
pmid:21924248
|
De Nuccio C et al. |
Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. |
2011 |
J. Neuropathol. Exp. Neurol. |
pmid:21937914
|
Gandhi UH et al. |
Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. |
2011 |
J. Biol. Chem. |
pmid:21669866
|
Charles RL et al. |
Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. |
2011 |
Circ. Res. |
pmid:21164107
|
Tang FT et al. |
Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. |
2011 |
Eur. J. Pharmacol. |
pmid:20854809
|
Li N et al. |
Molecular mechanisms underlying the inhibition of IFN-γ-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. |
2011 |
J. Cell. Biochem. |
pmid:21268089
|
Gijsbers L et al. |
Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression. |
2011 |
Anal. Biochem. |
pmid:21354099
|
Wang JJ and Mak OT |
Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGDâ‚‚ metabolite, 15d-PGJâ‚‚. |
2011 |
Cell Biol. Int. |
pmid:21999315
|
Seno T et al. |
15-Deoxy-Δ¹²,¹ⴠprostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. |
2011 |
PLoS ONE |
pmid:22003398
|
de Jong E et al. |
Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. |
2011 |
PLoS ONE |
pmid:21957481
|